Ted ear (right panel). (C) TSLP was measured by tissue ELISA of ears isolated from PBS-injected or IL-23-injected WT and CCR22/2 mice. Average of 3 mice per genotype. *p,0.005 CCR2 KO IL-23 vs. all other groups. (D) Representative immunofluorescence staining of ear skin isolated on day 12 from IL-23injected WT C57Bl/6 or CCR22/2 mice. Sections were stained with Ig isotype 
control antibody or anti-TSLP (x600, original magnification). Data are reflective of 3 mice per genotype. doi:10.1371/journal.pone.0058196.gIL-23 Induces Th2 get HIV-RT inhibitor 1 inflammation in CCR22/2 MiceDiscussionIn this study, we examined the role of the chemokine receptor CCR2 in a murine model of IL-23-induced psoriasis. The CCR2 ligand CCL2 is expressed by keratinocytes in psoriatic plaques [26,27], suggesting a potential role for CCR2 in psoriasis pathogenesis. In WT mice, intradermal IL-23 injection produces IL-22-dependent psoriasiform pathology, including acanthosis and dermal inflammatory infiltrates [8]. Here, we find that although IL-22 mRNA expression was comparable in the ears of IL-23injected CCR22/2 mice and WT mice, ears of CCR22/2 mice eventually became more inflamed with increased ear swelling and epidermal thickening. This increased inflammation correlated with increased cutaneous TSLP and IL-4 expression and increased numbers of eosinophils within the skin of CCR22/2 mice compared to WT mice. Previous studies have also detected increased Th2-type immune responses in CCR22/2 mice compared to WT mice using models of infection [34], inflammation [28,35] and transplant [36]. The increased Th2 responses observed in CCR22/2 mice have been correlated with decreased Th1-type responses. Since Th1-type and Th2-type cytokines are counter-regulatory [54], it has been speculated that the decreased Th1 response seen in CCR22/2 mice leads 
to an increased Th2 response in these mice [55,56]. However, in the IL-23 model of cutaneous inflammation we found comparable levels of Th1 (IFN-c) and Th17 (IL-17, IL-22) cytokines in the inflamed skin of WT and CCR22/2 mice. Rather, the increased Th2-type response we observed in CCR22/2 mice correlated with increased cutaneous TSLP expression. TSLP is an IL-7-like cytokine produced by several cell types, including keratinocytes [52], dendritic cells [57,58] and basophils [59]. TSLP promotes Th2-type immune responses through stimulation of dendritic cells [52,53], as well as by direct stimulation of CD4+ T cell [60] and mast cell [61] Th2 cytokine production. Additionally, TSLP promotes eosinophil survival and cytokine secretion [62]. Mice injected intradermally with TSLP [63] or transgenic for keratinocyte-specific TSLP expression [64] display hallmark features of atopic dermatitis, 17460038 including Th2 cytokine production, localized edema, acanthosis, hyperkeratosis and a dermal mononuclear cell infiltrate rich in eosinophils and mast cells. In this study, we found that TSLP was increased in the skin of CCR22/2 mice compared to WT mice. Similar to mice injected intradermally with TSLP or genetically Lixisenatide site engineered to overexpress TSLP in keratinocytes, the increased TSLP expression seen in CCR22/2 mice correlated with development of an atopic dermatitis-like cutaneous inflammation. We found that a Th2-type immune response, including increased IL-4 expression and accumulation of eosinophils and mast cells developed in IL-23injected CCR22/2 mouse skin, likely as a result of increased TSLP expression, but independent of an increased accumulationof Th2 cells.Ted ear (right panel). (C) TSLP was measured by tissue ELISA of ears isolated from PBS-injected or IL-23-injected WT and CCR22/2 mice. Average of 3 mice per genotype. *p,0.005 CCR2 KO IL-23 vs. all other groups. (D) Representative immunofluorescence staining of ear skin isolated on day 12 from IL-23injected WT C57Bl/6 or CCR22/2 mice. Sections were stained with Ig isotype control antibody or anti-TSLP (x600, original magnification). Data are reflective of 3 mice per genotype. doi:10.1371/journal.pone.0058196.gIL-23 Induces Th2 Inflammation in CCR22/2 MiceDiscussionIn this study, we examined the role of the chemokine receptor CCR2 in a murine model of IL-23-induced psoriasis. The CCR2 ligand CCL2 is expressed by keratinocytes in psoriatic plaques [26,27], suggesting a potential role for CCR2 in psoriasis pathogenesis. In WT mice, intradermal IL-23 injection produces IL-22-dependent psoriasiform pathology, including acanthosis and dermal inflammatory infiltrates [8]. Here, we find that although IL-22 mRNA expression was comparable in the ears of IL-23injected CCR22/2 mice and WT mice, ears of CCR22/2 mice eventually became more inflamed with increased ear swelling and epidermal thickening. This increased inflammation correlated with increased cutaneous TSLP and IL-4 expression and increased numbers of eosinophils within the skin of CCR22/2 mice compared to WT mice. Previous studies have also detected increased Th2-type immune responses in CCR22/2 mice compared to WT mice using models of infection [34], inflammation [28,35] and transplant [36]. The increased Th2 responses observed in CCR22/2 mice have been correlated with decreased Th1-type responses. Since Th1-type and Th2-type cytokines are counter-regulatory [54], it has been speculated that the decreased Th1 response seen in CCR22/2 mice leads to an increased Th2 response in these mice [55,56]. However, in the IL-23 model of cutaneous inflammation we found comparable levels of Th1 (IFN-c) and Th17 (IL-17, IL-22) cytokines in the inflamed skin of WT and CCR22/2 mice. Rather, the increased Th2-type response we observed in CCR22/2 mice correlated with increased cutaneous TSLP expression. TSLP is an IL-7-like cytokine produced by several cell types, including keratinocytes [52], dendritic cells [57,58] and basophils [59]. TSLP promotes Th2-type immune responses through stimulation of dendritic cells [52,53], as well as by direct stimulation of CD4+ T cell [60] and mast cell [61] Th2 cytokine production. Additionally, TSLP promotes eosinophil survival and cytokine secretion [62]. Mice injected intradermally with TSLP [63] or transgenic for keratinocyte-specific TSLP expression [64] display hallmark features of atopic dermatitis, 17460038 including Th2 cytokine production, localized edema, acanthosis, hyperkeratosis and a dermal mononuclear cell infiltrate rich in eosinophils and mast cells. In this study, we found that TSLP was increased in the skin of CCR22/2 mice compared to WT mice. Similar to mice injected intradermally with TSLP or genetically engineered to overexpress TSLP in keratinocytes, the increased TSLP expression seen in CCR22/2 mice correlated with development of an atopic dermatitis-like cutaneous inflammation. We found that a Th2-type immune response, including increased IL-4 expression and accumulation of eosinophils and mast cells developed in IL-23injected CCR22/2 mouse skin, likely as a result of increased TSLP expression, but independent of an increased accumulationof Th2 cells.